circRNA hsa_circ_0018414 inhibits the progression of LUAD by sponging miR-6807-3p and upregulating DKK1

被引:35
作者
Yao, Yuanshan [1 ]
Zhou, Yinjie [1 ]
Hua, Qingwang [1 ]
机构
[1] Univ Chinese Acad Sci, Hwa Mei Hosp, Dept Thorac Surg, Ningbo Hosp 2, 41 Northwest St, Ningbo 315010, Zhejiang, Peoples R China
来源
MOLECULAR THERAPY-NUCLEIC ACIDS | 2021年 / 23卷
关键词
LUNG ADENOCARCINOMA; CIRCULAR RNAS; PROMOTES; CANCER; PROLIFERATION;
D O I
10.1016/j.omtn.2020.12.031
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Lung adenocarcinoma (LUAD) is a subtype of lung cancer with a high incidence and mortality all over the world. In recent years, circular RNAs (circRNAs) have been verified to be a novel subtype of noncoding RNAs that exert vital functions in various cancers. Our research was designed to investigate the role of circ_0018414 in LUAD. We first observed that circ_0018414 was downregulated in LUAD tissues and cells. Also, low expression of circ_0018414 predicted unfavorable prognosis of LUAD patients. Then, upregulation of circ_0018414 repressed cell proliferation and stemness, while promoting cell apoptosis, in LUAD. Moreover, circ_0018414 overexpression enhanced the expression of its host gene, dickkopf WNT signaling pathway inhibitor 1 (DKK1), therefore inactivating the Wnt/beta-catenin pathway. Additionally, circ_0018414 could sponge miR-6807-3p to protect DKK1 mRNA from miR-6807-3p-induced silencing, leading to DKK1 upregulation in LUAD cells. Finally, rescue assays proved that circ_0018414 inhibited the progression of LUAD via the miR-6807-3p/DKK1 axis-inactivated Wnt/beta-catenin pathway. The findings in our work indicated circ_0018414 as a tumor inhibitor in LUAD, which might provide a new perspective for LUAD treatment.
引用
收藏
页码:783 / 796
页数:14
相关论文
共 50 条
  • [31] Hsa_circ_0000129 drives tumor growth via sequestering miR-485-3p and upregulating SPIN1 in breast cancer
    Zhou, Yuxin
    Wu, Minhua
    Wen, Limu
    Wu, Weizhu
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2023, 37 (02)
  • [32] Downregulation of hsa_circ_0007580 inhibits non-small cell lung cancer tumorigenesis by reducing miR-545-3p sponging
    Chen, Shuifang
    Lu, Shan
    Yao, Yinan
    Chen, Junjun
    Yang, Guangdie
    Tu, Lingfang
    Zhang, Zeying
    Zhang, Jianli
    Chen, Lina
    AGING-US, 2020, 12 (14): : 14329 - 14340
  • [33] Circular RNA hsa_circ_0007444 inhibits ovarian cancer progression through miR-23a-3p/DICER1 axis
    Zhang, Min
    Sun, Yu
    Xu, Hanzi
    Shi, Yaqian
    Shen, Rong
    Teng, Fang
    Xu, Juan
    Jia, Xuemei
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2023, 55 (04) : 574 - 586
  • [34] Circ_0027599/PHDLA1 suppresses gastric cancer progression by sponging miR-101-3p.1
    Wang, Liang
    Shen, Jingyan
    Jiang, Yushan
    CELL AND BIOSCIENCE, 2018, 8
  • [35] Hsa_circ_0003645 Promotes Breast Cancer Progression by Regulating miR-139-3p/HMGB1 Axis
    Zhang, Jinjun
    Ke, Shun
    Zheng, Weihong
    Zhu, Zhi
    Wu, Yanle
    ONCOTARGETS AND THERAPY, 2020, 13 : 10361 - 10372
  • [36] Circular RNA hsa_circ_0000073 contributes to osteosarcoma cell proliferation, migration, invasion and methotrexate resistance by sponging miR-145-5p and miR-151-3p and upregulating NRAS
    Li, Xia
    Liu, Yi
    Zhang, Xiangxin
    Shen, Jun
    Xu, Renjie
    Liu, Yubo
    Yu, Xiao
    AGING-US, 2020, 12 (14): : 14157 - 14173
  • [37] Knockdown of lncRNA PVT1 inhibits retinoblastoma progression by sponging miR-488-3p
    Wu, Xue-Zhi
    Cui, Hong-Pei
    Lv, Hai-Jiang
    Feng, Lei
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 112
  • [38] hsa_circ_0062389 promotes the progression of non-small cell lung cancer by sponging miR-103a-3p to mediate CCNE1 expression
    She, Yahui
    Han, Yuanyuan
    Zhou, Guangting
    Jia, Fangyan
    Yang, Tan
    Shen, Zuojun
    CANCER GENETICS, 2020, 241 : 12 - 19
  • [39] hsa_circ_0020378 regulating miR-339-3p/COL1A1 promotes osteosarcoma progression
    Liu, Liang
    Huang, Wenze
    CANCER BIOLOGY & THERAPY, 2023, 24 (01)
  • [40] The Involvement of the hsa_circ_0088494-miR-876-3p-CTNNB1/CCND1 Axis in Carcinogenesis and Progression of Papillary Thyroid Carcinoma
    Lou, Weiyang
    Ding, Bisha
    Wang, Jiannan
    Xu, Yongfang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8